Envoy Medical, Inc.
COCH
$1.42
$0.042.90%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -504.89% | 70.20% | 52.69% | 57.47% | 209.93% |
| Total Depreciation and Amortization | 68.97% | 44.83% | 25.93% | 84.62% | 31.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 138.97% | -115.99% | -83.36% | -101.01% | -858.54% |
| Change in Net Operating Assets | -74.78% | 3.33% | -263.77% | -1,485.31% | 817.50% |
| Cash from Operations | -355.41% | -21.67% | -94.15% | -392.14% | 144.35% |
| Capital Expenditure | -1,766.13% | -2,154.55% | -84.75% | 48.78% | 18.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -891.94% | -7,081.82% | -84.75% | 48.78% | 18.42% |
| Total Debt Issued | 150.00% | -16.67% | 25.00% | -100.00% | 0.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 12,656.52% |
| Cash from Financing | -61.23% | -16.67% | 67.08% | -144.55% | 408.93% |
| Foreign Exchange rate Adjustments | 0.00% | 0.00% | -200.00% | 66.67% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -84.03% | -205.83% | -21.91% | -2,862.91% | 3,023.28% |
